supported by the National Basic Research Program of China(973 project,grant number:2014CB542902);Tianjin Hongrentang Pharmaceutical Co.,Ltd.,Tianjin,China(grant number:HX202016)。
Objective: This study aimed to explore the effects of Chinese patent medicine(CPM) in reducing the incidence of major adverse cardiovascular events(MACE) in patients with coronary heart disease(CHD) angina pectoris an...
the National Key Basic Research Program of China(No.2015CB5540007);the National Natural Science Foundation of China(No.81572413,No.81702386);the Fundamental Research Funds for the Central Universities(No.2017KFYXJJ256);Scientific and Technological Application Foundation Project of Wuhan(No.2015060101010044).
Hepatoid adenocarcinoma of the stomach (HAS)is an extremely rare and unique gastric malignancy.The present study aimed to examine the relevance of the clinicopathological characteristics of HAS with patient prognosis....
supported by the National Natural Science Foundation of China(Nos.30771501 and 81102850);the National Basic Research Program(973)of China(No.2011CB811302);the National Mega Project on Major Drug Development(No.2009ZX09301-014-1);the Chinese 111 Project(No.B06018);the Wuhan Municipal Project(No.201160923296),China
Objective: To evaluate the potential adjuvant effect of Agrocybe aegerita lectin(AAL), which was isolated from mushroom, against a virulent H_9N_2 strain in vivo and in vitro. Methods: In trial 1, 50 BALB/c male mice(...
supported by the Infectious Disease Prevention and Control Major Research plan from the Ministry of Science and Technology of China-the Platform of Construction of Clinical Trial of Vaccine. (Project number 2009ZX0004-806)
Objective To evaluate the effect of the aluminum hydroxide (Al-OH) adjuvant on the 2009 pandemic influenza A/H1N1 (pH1N1) vaccine. Methods In a multicenter, double-blind, randomized, placebo-controlled trial, part...
supported by the National Natural Science Foundation of China (30670097);National Basic Research Program of China (973 Program) (2005CB522903);National Key R&D Program (2007BAI28B04);National S&T Major Project on Major Infectious Diseases (2008ZX10001-010)from the Ministry of Science and Technology of the People’s Republic of China
Severe Acute Respiratory Syndrome (SARS) is a deadly infectious disease caused by SARS Coronavirus (SARS-CoV). Inactivated SARS-CoV has been explored as a vaccine against SARS-CoV. However, safe and potent adjuvan...
Supported by the 973 key research finance of the state(2002CB 513000-07 ).
Objective To investigate the expression of discoidin domain receptor 2 (DDR2) of fibroblast-like synovial cells in im- proved adjuvant-induced animal (AIA) model for rheumatoid arthritis (RA) and to provide evidence f...